CD70 and acute myeloid leukemia: CD70 is a promising target for CAR-T cell therapy against AML because it is expressed on AML bulk cells, leukemic stem cells (LSCs), and has little to almost no expression on normal hematopoietic cells (HSCs) and normal bone marrow cells [83].